The opportunity
The primary responsibility of the role is to provide comprehensive Financial Evaluations for Generic and Biosimilars Projects. The position will also assist with set up, analysis, tracking and review of significant 3rd party transactions including Royalty payments and True Ups.
Location: This is a hybrid role (3 days/week in office) based in our Parsippany, NJ office
How you’ll spend your day
Lead/support financial evaluations for Biosimilars and Generics areas while working closely with business areas including Commercial, Manufacturing, Supply Chain, Business Development, Legal and R&D Team members.
Develop financial scenario analyses using business variables and identify and recommend optimal decisions pathways with value implications for management decision support along with Risks and Opportunities.
Provide overall program management support to the Generics and Biosimilars Finance area including clear communication regarding the timelines and deliverables of all FP&A Activities.
Consolidate and track high value items for US Generics and Biosimilars area such as major partnership true ups, etc.
Provide ongoing Systems related support to Biosimilars area including ensuring accuracy of financial data in the systems, loading forecasts and plans and checking the accuracy of the costing information.
Delivers financial presentations to key members of the leadership team.
Carries out responsibilities in accordance with the organization’s policies, procedures, and state, federal and local laws
Embrace additional ad hoc assignments, showcasing your agility and commitment to delivering exceptional results as needed.
